JUVE LOOK 50mg x 1vial

Description

Juvelook is a hybrid filler that combines both the benefits of an immediate filling effect, resulting from the use of HA hyaluronic acid, and long-term stimulation of collagen production, thanks to the use of polylactic acid PDLLA (Poly D, L – lactide)

Thanks to the patented production technology, a preparation with unique properties has been created: long-term effectiveness and an increased safety profile.

Intended use:

• Shadows under the eyes
• Volume loss in the lower eyelid area
• Marked valley of tears
• Flaccidity of the skin of the neck, skin of the hands, skin of the face
• Brightening and firming the skin
• Rejuvenation of the eye area
• Wrinkle smoothing
• Permanent tension and nourishment of the skin

Areas of application:

• eye area: lower eyelid, crow’s feet, tear trough
• forehead
• skin mesotherapy: face, neck and cleavage

Therapy effects

The effects of therapy are visible immediately after administration. We obtain the effect of filling thanks to the presence of hyaluronic acid. After about 2 weeks, collagen production begins with the presence of PDLLA lactic acid microparticles. The effects of the therapy last for more than two years after the last treatment. The recommended number of treatments is 2 or 3 depending on the skin defect at 6-8 week intervals. After two years, it is recommended to perform 1 booster treatment.

How to use:

• Intradermally and subcutaneously to a depth of approx. 1.7mm – 2.2mm.
• Recommended needle size – 30-31G, cannula – 27G.
• Recommended number of sessions: 2-3 treatments at an interval of 6-8 weeks.
• Administration technique: deposit.
• The product should be dissolved in 0.75ml of saline for injection and combined using a Vortex shaker. Centrifuge for 3 minutes, wait 5 minutes and centrifuge again for 3 minutes. Then check the preparation for undissolved particles and repeat the previous step if necessary.

Strengths of JUVELOOK:

• the world’s only Poly D,L Lactyd + HA hybrid formula with a particle size of 10 to 40 microns
• effectiveness and safety confirmed by clinical trials
• durability of the effects – more than 2 years from the last treatment
• immediate effect – due to hyaluronic acid
• safety – FDA, CE certificates for polylactic acid
• patents and own clinical trials
• particle size from 10 to 40 microns
• comfort of the procedure – ease of injection and no needle clogging during the procedure

Composition

• Polylactic acid (PDLLA – Poly D, L Lactyd) 42.5 mg (particle size 10-40 microns)
• Non-crosslinked hyaluronic acid 7.5mg (particle size 3000kDa)